Skip to content
Sleep & circadian healthRandomised trial4 min read

App-based insomnia therapy cut new major depression in young people: 10% vs 18% over 12 months

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial. · PLoS medicine · 2025 · Original paper ↗

Key takeaway

In 708 Chinese youths aged 15 to 25 with insomnia and mild depressive symptoms, 6 weeks of app-based cognitive behavioral therapy for insomnia led to major depressive disorder in 37 (10%) versus 62 (18%) of those given health education (HR 0.58; 95% CI 0.38-0.87). Outcomes were assessed by phone interviews and online forms, and the control app was health education rather than an inactive control.

Study design

Randomised trial

Reading basis

Published abstract

Reading focus

Comparator & uncertainty

The research question

Insomnia appears to play a role in the development of depression, so treating it might help prevent depression in young people. The authors tested whether a smartphone app delivering cognitive behavioral therapy for insomnia (CBT-I) could prevent new major depressive disorder (MDD) in youth with insomnia and subclinical depressive symptoms.

Who and how

Randomized, assessor-blind, parallel-group trial in Chinese youths aged 15-25 with insomnia disorder and subclinical depressive symptoms, enrolled between September 9, 2019 and November 25, 2022. 708 participants were randomized 1:1 to 6 weeks of app-based CBT-I (n = 354) or app-based health education (n = 354). Online assessments and telephone clinical interviews took place at baseline, post-intervention, and 6- and 12-month follow-ups. The primary outcome was time to onset of MDD; secondary outcomes were depressive symptoms and insomnia at symptom and disorder levels.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    708 youths took part (407 female, 57%; mean age 22.1 years, SD 1.9).
  2. 2
    New-onset MDD over 12 months occurred in 37 (10%) of the CBT-I group and 62 (18%) of the control group (hazard ratio 0.58; 95% CI 0.38-0.87; p = 0.008). The number needed to treat to prevent one case of MDD at 1 year was 10.9 (6.8-26.6).
  3. 3
    Insomnia disorder remitted in 52% of the CBT-I group versus 28% of controls right after treatment (relative risk 1.83, 1.49-2.24; p < 0.001), and the advantage persisted through 12 months.
  4. 4
    Compared with controls, the CBT-I group had larger drops in depressive symptoms (adjusted difference -1.0, -1.6 to -0.5; Cohen's d = 0.53; p < 0.001) and insomnia symptoms (-2.0, -2.7 to -1.3; d = 0.78; p < 0.001) after treatment and through 6-month follow-up.
  5. 5
    Insomnia mediated the effect of the intervention on depression. No intervention-related adverse events were reported.

Limits & uncertainty

  1. 1
    Participants were Chinese youths with insomnia and subclinical depression, so the results may not apply to people with different backgrounds or without insomnia.
  2. 2
    The comparison group received health education, so the trial shows an advantage over that control, not over no intervention or over other sleep treatments.
  3. 3
    The 95% CI for the number needed to treat (6.8-26.6) is wide, so the practical benefit per person is uncertain.
  4. 4
    Symptom outcomes rely on self-report, and symptom benefits are described through 6 months, not 12. This reading is based on the abstract only.

What to take from it

This suggests that treating insomnia early with a structured digital programme may lower the chance of a depressive episode in young people with poor sleep and low mood. It does not replace care for someone already depressed, and decisions about treatment should be made with a clinician.

Reading your own data

A sleep tracker can show your bedtime regularity, total sleep time and time awake at night, which are the kinds of patterns CBT-I programmes work on. Wearable sleep estimates are approximate and cannot detect insomnia disorder or depression, so judge them by trends over weeks on the same device alongside how you feel.

How to read this evidence

Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Increasing evidence suggests that insomnia plays an important role in the development of depression, supporting insomnia intervention as a promising approach to prevent depression in youth. This randomized controlled trial evaluated the effectiveness of app-based cognitive behavioral therapy for insomnia (CBT-I) in preventing future onset of major depressive disorder (MDD) in youth.

Methods and findings

This was a randomized, assessor-blind, parallel group-controlled trial in Chinese youth (aged 15-25 years) with insomnia disorder and subclinical depressive symptoms. Participants were randomly assigned (1:1) to 6-week app-based CBT-I or 6-week app-based health education (HE) delivered through smartphones. Online assessments and telephone clinical interviews were conducted at baseline, post-intervention, 6- and 12-month follow-ups. The primary outcome was time to onset of MDD. The secondary outcomes included depressive symptoms and insomnia at both symptom and disorder levels. Between September 9, 2019, and November 25, 2022, 708 participants (407 females [57%]; mean age, 22.1 years [SD = 1.9]) were randomly allocated to app-based CBT-I group (n = 354) or app-based HE group (n = 354). Thirty-seven participants (10%) in the intervention group and 62 participants (18%) in the control group developed new-onset MDD throughout the 12-month follow-up, with a hazard ratio of 0.58 (95% confidence interval 0.38-0.87; p = 0.008). The number needed to treat to prevent MDD at 1 year was 10.9 (6.8-26.6). The app-based CBT-I group has higher remission rates of insomnia disorder than the controls at post-intervention (52% versus 28%; relative risk 1.83 [1.49-2.24]; p < 0.001) and throughout 12-month follow-up. In addition, the CBT-I group reported a greater decrease in depressive (adjusted difference -1.0 [-1.6 to -0.5]; Cohen's d = 0.53; p < 0.001) and insomnia symptoms (-2.0 [-2.7 to -1.3], d = 0.78; p < 0.001) than the controls at post-intervention and throughout 6-month follow-up. Insomnia was a mediator of intervention effects on depression. No adverse events related to the interventions were reported.

Conclusions

App-based CBT-I is effective in preventing future onset of major depression and improving insomnia outcomes among youth with insomnia and subclinical depression. These findings highlight the importance of targeting insomnia to prevent the onset of MDD and emphasize the need for wider dissemination of digital CBT-I to promote sleep and mental health in the youth population.

Trial registration

ClinicalTrials.Gov (NCT04069247).

Sources & attribution

Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial.

Chen SJ, Que JY, Chan NY, Shi L, Li SX, Chan JWY, Huang W, Chen CX, Tsang CC, Ho YL, Morin CM, Zhang JH, Lu L, Wing YK.

PLoS medicine · 2025-01-21

DOI: 10.1371/journal.pmed.1004510 ↗PubMed · 39836656 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Trial meta-analysis

Exercise improved sleep-quality scores in adults 45 and older with sleep disorders

Pooling 23 randomized trials with 1,478 adults aged 45 to 77 who had sleep disorders, exercise improved Pittsburgh Sleep Quality Index scores (SMD 0.62, 95% CI 0.40–0.83), and aerobic exercise showed the largest effect in the network analysis (SMD 1.34, 95% CrI 0.86–1.82). Certainty was low to moderate, the outcomes were questionnaires, and the best weekly dose of about 539 MET-min/week is a model estimate, not a prescription.

Journal of Exercise Science & Fitness

In-depth explainersRead study →
·Cohort study

Sleep regularity tracked mortality more closely than sleep duration in 60,977 UK adults

Among 60,977 UK Biobank adults who wore a wrist accelerometer for a week, the most regular fifth of sleepers had a fully adjusted all-cause mortality HR of 0.70 (95% CI 0.59–0.83) against the least regular fifth, over about 6.3 years and 1859 deaths. Regularity fitted the data better than sleep duration, but the study is observational and rests on one week of sleep data.

Sleep

In-depth explainersRead study →
·Randomised trial

Sleep extension cut daily energy intake by about 270 kcal in adults with overweight

In 80 adults with overweight who usually slept under 6.5 hours, two weeks of sleep-extension counselling added about 1.2 hours of sleep and lowered measured energy intake by 270.4 kcal/d versus control (95% CI −393.4 to −147.4). The trial was short, single-centre and in a narrow group, so it does not show lasting weight loss or any benefit for people who already sleep enough.

JAMA Internal Medicine

In-depth explainersRead study →
·Cohort study

Six hours or less of sleep at 50 and 60 linked to higher dementia risk

In 7959 British civil servants followed for about 25 years, sleeping six hours or less at age 50 (HR 1.22, 95% CI 1.01–1.48) or age 60 (HR 1.37, 1.10–1.72) was linked to a higher dementia rate than sleeping seven hours, and persistent short sleep gave an HR of 1.30 (1.00–1.69). Sleep was mostly self-reported and the study is observational, so early brain disease or other factors may explain part of the link.

Nature Communications

In-depth explainersRead study →
Sleep & circadian health →